{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:46:00Z","timestamp":1790801160207,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Office of the Vice President for Research, University of Minnesota, College of Pharmacy\/College of Veterinary Medicine (COP\/CVM)"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.biomaterials.2016.02.024","type":"journal-article","created":{"date-parts":[[2016,2,21]],"date-time":"2016-02-21T14:15:39Z","timestamp":1456064139000},"page":"97-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Glycoengineered mesenchymal stem cells as an enabling platform for two-step targeting of solid tumors"],"prefix":"10.1016","volume":"88","author":[{"given":"Buddhadev","family":"Layek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmoy","family":"Sadhukha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swayam","family":"Prabha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2016.02.024_bib1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.molonc.2010.08.003","article-title":"Targeted nanoagents for the detection of cancers","volume":"4","author":"McCarthy","year":"2010","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib2","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1158\/1078-0432.CCR-07-1951","article-title":"Tumor-targeting nanocomplex delivery of novel tumor suppressor RB94 chemosensitizes bladder carcinoma cells in\u00a0vitro and in\u00a0vivo","volume":"14","author":"Pirollo","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib3","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1517\/17425247.2010.513968","article-title":"Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer","volume":"7","author":"Wang","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib4","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1016\/j.biomaterials.2009.07.048","article-title":"Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery","volume":"30","author":"Prabaharan","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib6","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3892\/or.2015.4136","article-title":"Targeted delivery of doxorubicin to breast cancer cells by aptamer functionalized DOTAP\/DOPE liposomes","volume":"34","author":"Song","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2014.06.039","article-title":"Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor","volume":"192","author":"Valetti","year":"2014","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib11","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1021\/nl072209h","article-title":"A\u00a0cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors","volume":"7","author":"Choi","year":"2007","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib12","first-page":"885","article-title":"Imaging tumor hypoxia and tumor perfusion","volume":"34","author":"Groshar","year":"1993","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/978-1-60761-999-4_33","article-title":"Metabolic labeling and click chemistry detection of glycoprotein markers of mesenchymal stem cell differentiation","volume":"698","author":"Hart","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.7150\/thno.7265","article-title":"Cell labeling and tracking method without distorted signals by phagocytosis of macrophages","volume":"4","author":"Kang","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib15","doi-asserted-by":"crossref","first-page":"11836","DOI":"10.1002\/anie.201206703","article-title":"Bioorthogonal copper-free click chemistry in\u00a0vivo for tumor-targeted delivery of nanoparticles","volume":"51","author":"Koo","year":"2012","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib16","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/anie.200705456","article-title":"Visualizing metabolically labeled glycoconjugates of living cells by copper-free and fast huisgen cycloadditions","volume":"47","author":"Ning","year":"2008","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib17","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1021\/nn406584y","article-title":"Chemical tumor-targeting of nanoparticles based on metabolic glycoengineering and click chemistry","volume":"8","author":"Lee","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1349-7006.2005.00032.x","article-title":"Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy","volume":"96","author":"Hamada","year":"2005","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2015.03.002","article-title":"Engineering mesenchymal stem cells for regenerative medicine and drug delivery","volume":"84","author":"Park","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1756-8722-7-14","article-title":"The roles of mesenchymal stem cells in tumor inflammatory microenvironment","volume":"7","author":"Sun","year":"2014","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/mt.2008.3","article-title":"A\u00a0tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs","volume":"16","author":"Chen","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.addr.2011.06.010","article-title":"Mesenchymal stem cells engineered for cancer therapy","volume":"64","author":"Shah","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib23","doi-asserted-by":"crossref","first-page":"8393","DOI":"10.1016\/j.biomaterials.2010.07.048","article-title":"Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors","volume":"31","author":"Roger","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2014.10.015","article-title":"Nano-engineered mesenchymal stem cells as targeted therapeutic carriers","volume":"196","author":"Sadhukha","year":"2014","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib25","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1021\/mp900284c","article-title":"Interfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery","volume":"7","author":"Toti","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/aps.2013.50","article-title":"Mesenchymal stem cells: a new trend for cell therapy","volume":"34","author":"Wei","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2008.03.002","article-title":"Mesenchymal stem cells: revisiting history, concepts, and assays","volume":"2","author":"Bianco","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib28","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1634\/stemcells.2004-0058","article-title":"Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta","volume":"22","author":"In 't Anker","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/107632701300062859","article-title":"Multilineage cells from human adipose tissue: implications for cell-based therapies","volume":"7","author":"Zuk","year":"2001","journal-title":"Tissue Eng."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib31","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1089\/scd.2012.0486","article-title":"Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation","volume":"22","author":"Akimoto","year":"2013","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1476-4598-9-129","article-title":"Tumor cell behaviour modulation by mesenchymal stromal cells","volume":"9","author":"Kucerova","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canlet.2011.10.002","article-title":"Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in\u00a0vivo","volume":"315","author":"Zhu","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib34","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.20051921","article-title":"Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma","volume":"203","author":"Khakoo","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s000180050322","article-title":"Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice","volume":"55","author":"Maestroni","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib36","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.gt.3302276","article-title":"Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model","volume":"11","author":"Nakamura","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2009.02.011","article-title":"Naive human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in\u00a0vitro and in\u00a0vivo","volume":"280","author":"Ayuzawa","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib38","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3109\/14653240903548194","article-title":"Cytotherapy with naive rat umbilical cord matrix stem cells significantly attenuates growth of murine pancreatic cancer cells and increases survival in syngeneic mice","volume":"12","author":"Doi","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib39","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1158\/1078-0432.CCR-09-1938","article-title":"Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis","volume":"15","author":"Chanda","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib40","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2174\/138161212799859666","article-title":"Clinical applications and biosafety of human adult mesenchymal stem cells","volume":"18","author":"Mariani","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-8722-5-19","article-title":"Clinical applications of mesenchymal stem cells","volume":"5","author":"Wang","year":"2012","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3904\/kjim.2013.28.4.387","article-title":"Clinical applications of mesenchymal stem cells","volume":"28","author":"Kim","year":"2013","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib43","doi-asserted-by":"crossref","first-page":"26018","DOI":"10.18632\/oncotarget.4658","article-title":"Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages","volume":"6","author":"Jia","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib44","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/glycob\/cwp115","article-title":"Metabolic glycoengineering: sialic acid and beyond","volume":"19","author":"Du","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib45","doi-asserted-by":"crossref","first-page":"16793","DOI":"10.1073\/pnas.0707090104","article-title":"Copper-free click chemistry for dynamic in\u00a0vivo imaging","volume":"104","author":"Baskin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib46","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.1021\/bi9007726","article-title":"Click chemistry and bioorthogonal reactions: unprecedented selectivity in the labeling of biological molecules","volume":"48","author":"Best","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib47","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/cb300238w","article-title":"State-selective metabolic labeling of cellular proteins","volume":"7","author":"Ngo","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib48","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/ar.22602","article-title":"Use of fluorescent probes: their effect on cell biology and limitations","volume":"295","author":"Jensen","year":"2012","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib49","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1016\/j.bmcl.2008.09.010","article-title":"Fluorination of mammalian cell surfaces via the sialic acid biosynthetic pathway","volume":"18","author":"Dafik","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nchembio770","article-title":"Metabolic installation of thiols into sialic acid modulates adhesion and stem cell biology","volume":"2","author":"Sampathkumar","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib51","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3858\/emm.2011.43.10.069","article-title":"In\u00a0vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors","volume":"43","author":"Baek","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2015.01.003","article-title":"Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme\/prodrug systems","volume":"200","author":"Nouri","year":"2015","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib53","doi-asserted-by":"crossref","first-page":"e58198","DOI":"10.1371\/journal.pone.0058198","article-title":"Mesenchymal stem cells derived from adipose tissue vs bone marrow: in\u00a0vitro comparison of their tropism towards gliomas","volume":"8","author":"Pendleton","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib54","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1634\/stemcells.22-3-377","article-title":"Mesenchymal stem cells can be differentiated into endothelial cells in\u00a0vitro","volume":"22","author":"Oswald","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib55","doi-asserted-by":"crossref","first-page":"975871","DOI":"10.1155\/2012\/975871","article-title":"Markers for characterization of bone marrow multipotential stromal cells","volume":"2012","author":"Boxall","year":"2012","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib56","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1073\/pnas.97.7.3213","article-title":"Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow","volume":"97","author":"Colter","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib57","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/stem.1681","article-title":"Concise review: the surface markers and identity of human mesenchymal stem cells","volume":"32","author":"Lv","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2014.12.003","article-title":"Non-genetic engineering of cells for drug delivery and cell-based therapy","volume":"91","author":"Wang","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib59","doi-asserted-by":"crossref","first-page":"678063","DOI":"10.1155\/2013\/678063","article-title":"Biodistribution of mesenchymal stem\/stromal cells in a preclinical setting","volume":"2013","author":"Sensebe","year":"2013","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2011.02.012","article-title":"Potential implications of mesenchymal stem cells in cancer therapy","volume":"305","author":"Dai","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib61","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nano.2012.06.003","article-title":"Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles","volume":"9","author":"Gao","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib62","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1158\/0008-5472.CAN-08-4698","article-title":"Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer","volume":"69","author":"Loebinger","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib63","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1021\/nn901319y","article-title":"Nanoparticulate cellular patches for cell-mediated tumoritropic delivery","volume":"4","author":"Cheng","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib64","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2012.02.022","article-title":"Use of macrophages to deliver therapeutic and imaging contrast agents to tumors","volume":"33","author":"Choi","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib65","first-page":"276","article-title":"Vascular permeability factor gene expression in normal and neoplastic human ovaries","volume":"54","author":"Olson","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib66","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1158\/0008-5472.CAN-07-0172","article-title":"Endostatin binding to ovarian cancer cells inhibits peritoneal attachment and dissemination","volume":"67","author":"Yokoyama","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib67","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib68","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.addr.2012.10.002","article-title":"The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in\u00a0vivo","volume":"65","author":"Maeda","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib69","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1582-4934.2009.00920.x","article-title":"Mesenchymal stem cells modified to express lentivirus TNF-alpha Tumstatin(45-132) inhibit the growth of prostate cancer","volume":"15","author":"Zhang","year":"2011","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib70","doi-asserted-by":"crossref","first-page":"9027","DOI":"10.1021\/nn403617j","article-title":"In\u00a0vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles","volume":"7","author":"Chen","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib71","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/j.biomaterials.2010.12.061","article-title":"Single chain anti-c-Met antibody conjugated nanoparticles for in\u00a0vivo tumor-targeted imaging and drug delivery","volume":"32","author":"Lu","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2016.02.024_bib72","first-page":"1172","article-title":"Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery","volume":"8","author":"Park","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2016.02.024_bib73","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/anie.201105432","article-title":"Switching the targeting pathways of a therapeutic antibody by nanodesign","volume":"51","author":"Bhattacharyya","year":"2012","journal-title":"Angew. Chem. Int. Ed. Engl."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961216001381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961216001381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:15:20Z","timestamp":1758903320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961216001381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":73,"alternative-id":["S0142961216001381"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2016.02.024","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycoengineered mesenchymal stem cells as an enabling platform for two-step targeting of solid tumors","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2016.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}